You are here

Article Text

Article menu
Download PDFPDF
Cervical Cancer
Cervix Cancer Research Network (CCRN): Improving Access to Cervix Cancer Trials on a Global Scale
  1. David Gaffney, MD, PhD,
  2. Bill Small, MD,
  3. Henry Kitchener, MD,
  4. Sang Young Ryu, MD, PhD,
  5. Akila Viswanathan, MD, MPH,
  6. Ted Trimble, MD, MPH,
  7. Al Covens, MD,
  8. Sarikapan Wilailak, MD,
  9. Arb-aroon Lertkhachonsuk, MD,
  10. Chomporn Sitathanee, MD,
  11. Umesh Mahantshetty, MD,
  12. Brandon Fisher, MD,
  13. Susan Springer,
  14. Thomas Pollatz,
  15. Antonius Spiller,
  16. Monica Bacon, RN and
  17. Anuja Jhingran, MD
  1. * Department of Radiation Oncology, University of Utah, Salt Lake City, UT;
  2. † Department of Surgery, Loyola University, Chicago, IL;
  3. ‡ Institute of Cancer Sciences, University of Manchester, Manchester, UK;
  4. § Department of Obstetrics and Gynecology, Korea Cancer Center Hospital, Korea Institute of Radiological and Medical Sciences, Seoul, Korea;
  5. ∥ Department of Radiation Oncology, John Hopkins University, Baltimore, MD;
  6. National Cancer Institute, Washington, DC;
  7. # Sunnybrook Health Science Center, Toronto, Canada;
  8. ** Faculty of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand;
  9. †† Tata Memorial Hospital, Mumbai, India;
  10. ‡‡ Radiating Hope, Salt Lake City, UT;
  11. §§ Elekta, Veenendaal, the Netherlands;
  12. ∥∥ Varian Medical Systems, Palo Alto, CA;
  13. ¶¶ BEBIG, Lübeck Area, Germany;
  14. ## Gynecologic Cancer InterGroup, Kingston, Ontario, Canada; and
  15. *** The University of Texas MD Anderson Cancer Center, Houston, TX.
  1. Address correspondence and reprint requests to Anuja Jhingran, MD, The University of Texas MD Anderson Cancer Center, Houston, TX. E-mail: ajhingra{at}mdanderson.org.

Abstract

Abstract Eighty-seven percent of cervix cancer occurs in less-developed regions of the world, and there is up to an 18-fold difference in mortality rate for cervix cancer depending on the region of the world. The Cervix Cancer Research Network (CCRN) was founded through the Gynecologic Cancer InterGroup with the aim of improving access to clinical trials in cervix cancer worldwide, and in so doing improving standards of care. The CCRN recently held its first international educational symposium in Bangkok. Sixty-two participants attended from 16 different countries including Pakistan, India, Bangladesh, Thailand, Malaysia, Singapore, Philippines, Taiwan, China, Vietnam, Korea, Japan, Columbia, Brazil, Canada, and the United States. The focus of this symposium was to evaluate progress, to promote new clinical trials for the CCRN, and to provide education regarding the role of brachytherapy in the treatment of cervical cancer.

  • Cervix cancer
  • Cervical cancer
  • Brachytherapy
  • Radiotherapy
  • CCRN

https://doi.org/10.1097/IGC.0000000000000823

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Footnotes

    • The author declares no conflict of interest.